NHE-1: A promising target for novel anti-cancer therapeutics

Among the many factors involved in the maintenance of homeostatic growth is the tight regulation of cellular pH. Intracellular pH of normal cells is maintained within a physiological range thanks to the activity of a number of pH regulators that respond to the acid-base shifts associated with normal...

Full description

Bibliographic Details
Main Authors: Loo, S., Chang, M., Chua, C., Kumar, A., Pervaiz, Shazib, Clement, M.
Format: Journal Article
Published: 2012
Online Access:http://hdl.handle.net/20.500.11937/51282
_version_ 1848758659263234048
author Loo, S.
Chang, M.
Chua, C.
Kumar, A.
Pervaiz, Shazib
Clement, M.
author_facet Loo, S.
Chang, M.
Chua, C.
Kumar, A.
Pervaiz, Shazib
Clement, M.
author_sort Loo, S.
building Curtin Institutional Repository
collection Online Access
description Among the many factors involved in the maintenance of homeostatic growth is the tight regulation of cellular pH. Intracellular pH of normal cells is maintained within a physiological range thanks to the activity of a number of pH regulators that respond to the acid-base shifts associated with normal cellular metabolic processes. Interestingly, there is a preponderance of evidence that dysregulation of intracellular pH is associated with processes that favor cell transformation such as cell cycle progression, enhanced proliferation, insensitivity to growth inhibitory stimuli, resistance to apoptosis, genomic instability and angiogenesis. Among the strategies employed by the cells to regulate intracellular pH, the Na+/H+ exchanger 1 (NHE1) protein from the Na+/H+ exchanger (NHE) family has been directly associated with cellular transformation, invasion and metastasis. These observations have heightened the interest in NHE1 as a promising novel drug target for more effective and selective anti-cancer therapeutics. Here we present a review of the basic biology of this remarkable protein and present evidence to support targeting NHE1 as a potential anti-cancer strategy. © 2012 Bentham Science Publishers.
first_indexed 2025-11-14T09:47:30Z
format Journal Article
id curtin-20.500.11937-51282
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:47:30Z
publishDate 2012
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-512822017-03-17T08:30:10Z NHE-1: A promising target for novel anti-cancer therapeutics Loo, S. Chang, M. Chua, C. Kumar, A. Pervaiz, Shazib Clement, M. Among the many factors involved in the maintenance of homeostatic growth is the tight regulation of cellular pH. Intracellular pH of normal cells is maintained within a physiological range thanks to the activity of a number of pH regulators that respond to the acid-base shifts associated with normal cellular metabolic processes. Interestingly, there is a preponderance of evidence that dysregulation of intracellular pH is associated with processes that favor cell transformation such as cell cycle progression, enhanced proliferation, insensitivity to growth inhibitory stimuli, resistance to apoptosis, genomic instability and angiogenesis. Among the strategies employed by the cells to regulate intracellular pH, the Na+/H+ exchanger 1 (NHE1) protein from the Na+/H+ exchanger (NHE) family has been directly associated with cellular transformation, invasion and metastasis. These observations have heightened the interest in NHE1 as a promising novel drug target for more effective and selective anti-cancer therapeutics. Here we present a review of the basic biology of this remarkable protein and present evidence to support targeting NHE1 as a potential anti-cancer strategy. © 2012 Bentham Science Publishers. 2012 Journal Article http://hdl.handle.net/20.500.11937/51282 restricted
spellingShingle Loo, S.
Chang, M.
Chua, C.
Kumar, A.
Pervaiz, Shazib
Clement, M.
NHE-1: A promising target for novel anti-cancer therapeutics
title NHE-1: A promising target for novel anti-cancer therapeutics
title_full NHE-1: A promising target for novel anti-cancer therapeutics
title_fullStr NHE-1: A promising target for novel anti-cancer therapeutics
title_full_unstemmed NHE-1: A promising target for novel anti-cancer therapeutics
title_short NHE-1: A promising target for novel anti-cancer therapeutics
title_sort nhe-1: a promising target for novel anti-cancer therapeutics
url http://hdl.handle.net/20.500.11937/51282